Researchers said that the score further may identify patients whose treatment resistance may be overcome with combination strategies targeting certain cells.
Starting with genome sequences for thousands of individuals from Alzheimer's-affected families, researchers found rare disease-associated variants at 13 new loci.
Fresh off a name change, the company last week introduced a monitoring platform for new SARS-CoV-2 variants that alerts diagnostic test makers to potential problems.
Earlier this month, GranatumX, which uses a web-based graphical environment, was approved for the Human Cell Atlas Data Portal's analysis tools registry.
The analysis further found that low-risk tumors might develop from cells further along in development, while high-risk ones might develop from earlier-stage cells.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
